Leading pharmaceutical M&A deal value in China 2019, by acquirer

Published by
Wenyi Zhang,
Jan 27, 2022
The American multinational biotechnology company Amgen Inc. spent about 2.8 billion U.S. dollars to acquire the biopharmaceutical company BeiGene Ltd in October 2019 - the largest M&A investment deal made in China's pharmaceutical sector that year. It was the only foreign investment among the top ten M&A deals.

Value of leading investment deals of mergers and acquisitions(M&A) in the pharmaceutical sector in China as of 2019, by acquirer (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2020

Region

China

Survey time period

2019

Supplementary notes

*Other acquirers involved in the investment deal included OrbiMed Capital, Yongjin Capital, Hillhouse Capital, Cormorant, Vivo, Shanghai Pharma (HK).

The deal value figures refer only to the deals whereby a value has been publicly disclosed.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

9

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceuticals in IndiaGlobal pharmaceutical industryPrivate equity and venture capital in IndiaState of health in IndiaCoronavirus (COVID-19) in India
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu